DK0929517T3 - Hydroxamsyrederivater - Google Patents

Hydroxamsyrederivater

Info

Publication number
DK0929517T3
DK0929517T3 DK97909339T DK97909339T DK0929517T3 DK 0929517 T3 DK0929517 T3 DK 0929517T3 DK 97909339 T DK97909339 T DK 97909339T DK 97909339 T DK97909339 T DK 97909339T DK 0929517 T3 DK0929517 T3 DK 0929517T3
Authority
DK
Denmark
Prior art keywords
hydroxamic acid
hydroxamic
acid
Prior art date
Application number
DK97909339T
Other languages
English (en)
Inventor
Georg Kottirsch
Ulf Neumann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620572.9A external-priority patent/GB9620572D0/en
Priority claimed from GBGB9706667.4A external-priority patent/GB9706667D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0929517T3 publication Critical patent/DK0929517T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DK97909339T 1996-10-02 1997-09-30 Hydroxamsyrederivater DK0929517T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9620572.9A GB9620572D0 (en) 1996-10-02 1996-10-02 Organic compounds
GBGB9706667.4A GB9706667D0 (en) 1997-04-02 1997-04-02 Organic compounds
PCT/EP1997/005376 WO1998014424A1 (en) 1996-10-02 1997-09-30 Hydroxamic acid derivatives

Publications (1)

Publication Number Publication Date
DK0929517T3 true DK0929517T3 (da) 2002-10-07

Family

ID=26310147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97909339T DK0929517T3 (da) 1996-10-02 1997-09-30 Hydroxamsyrederivater

Country Status (28)

Country Link
EP (1) EP0929517B1 (da)
JP (1) JP3444898B2 (da)
KR (1) KR20000048811A (da)
CN (1) CN1101807C (da)
AR (1) AR009103A1 (da)
AT (1) ATE219050T1 (da)
AU (1) AU726065B2 (da)
BR (1) BR9712255A (da)
CA (1) CA2267415A1 (da)
CO (1) CO4900034A1 (da)
CZ (1) CZ113999A3 (da)
DE (1) DE69713354T2 (da)
DK (1) DK0929517T3 (da)
ES (1) ES2178759T3 (da)
HU (1) HUP9903892A3 (da)
ID (1) ID22212A (da)
IL (1) IL129166A0 (da)
MY (1) MY127926A (da)
NO (1) NO313457B1 (da)
NZ (1) NZ334908A (da)
PE (1) PE2099A1 (da)
PL (1) PL188518B1 (da)
PT (1) PT929517E (da)
RU (1) RU2196131C2 (da)
SI (1) SI0929517T1 (da)
SK (1) SK43099A3 (da)
TR (1) TR199900725T2 (da)
WO (1) WO1998014424A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294917A1 (en) * 2002-12-20 2004-07-14 Novartis Ag Device and method for delivering mmp inhibitors
CA2534352A1 (en) 2003-08-08 2005-02-17 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
CA2559062A1 (en) 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
CN1951912B (zh) * 2005-10-18 2010-05-05 上海五洲药业股份有限公司 手性脂环烃异羟肟酸衍生物的制备方法
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
KR102410199B1 (ko) * 2016-04-18 2022-06-17 프라운호퍼-게젤샤프트 츄어 푀르더룽 데어 안게반텐 포르슝에.파우. 새로운 메프린 알파 및 베타 저해제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
DE69502378T2 (de) * 1994-01-20 1998-10-01 British Biotech Pharm Metalloproteinaseinhibitoren
FI962905A0 (fi) * 1994-01-22 1996-07-19 British Biotech Pharm Metalloproteinaasi-inhibiittoreita
GB9416897D0 (en) * 1994-08-20 1994-10-12 British Biotech Pharm Metalloproteinase inhibitors
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
JP3444898B2 (ja) 2003-09-08
EP0929517B1 (en) 2002-06-12
JP2000508338A (ja) 2000-07-04
KR20000048811A (ko) 2000-07-25
IL129166A0 (en) 2000-02-17
CA2267415A1 (en) 1998-04-09
NO313457B1 (no) 2002-10-07
DE69713354D1 (de) 2002-07-18
CZ113999A3 (cs) 1999-06-16
PL332477A1 (en) 1999-09-13
NO991559L (no) 1999-03-30
DE69713354T2 (de) 2002-12-05
NO991559D0 (no) 1999-03-30
AR009103A1 (es) 2000-03-08
CO4900034A1 (es) 2000-03-27
RU2196131C2 (ru) 2003-01-10
HUP9903892A3 (en) 2000-04-28
NZ334908A (en) 2000-10-27
ID22212A (id) 1999-09-16
PL188518B1 (pl) 2005-02-28
CN1232447A (zh) 1999-10-20
PE2099A1 (es) 1999-02-08
ES2178759T3 (es) 2003-01-01
ATE219050T1 (de) 2002-06-15
HUP9903892A2 (hu) 2000-03-28
AU726065B2 (en) 2000-10-26
WO1998014424A1 (en) 1998-04-09
HK1021637A1 (en) 2000-06-23
SK43099A3 (en) 1999-08-06
EP0929517A1 (en) 1999-07-21
PT929517E (pt) 2002-10-31
BR9712255A (pt) 1999-08-24
TR199900725T2 (xx) 1999-07-21
AU4706897A (en) 1998-04-24
SI0929517T1 (en) 2002-10-31
CN1101807C (zh) 2003-02-19
MY127926A (en) 2006-12-29

Similar Documents

Publication Publication Date Title
IS5340A (is) Arýloxýarýlsúlfónýlamínó hýdroxamsýru afleiður
IS4958A (is) Arýlsúlfónýlamínó hýdroxamíðsýru afleiður
DK0977733T3 (da) Arylsulfonylaminohydroxamsyrederivater
FI951962A7 (fi) Hydroksaamihappojohdannaiset
DE69721098D1 (de) Entwicklungsgerät
ATE208395T1 (de) Thiophenopyrimidine
DE69720097D1 (de) Entwicklungsgerät
ATE262512T1 (de) Arylalkanoylpyridazine
DE69715313D1 (de) Entwicklungsgerät
ATE208773T1 (de) Chinoxalindione
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
KR980000769U (ko) 병상
NO991561D0 (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
DK0929517T3 (da) Hydroxamsyrederivater
ATE212975T1 (de) Carbamoylcarbonsäureamidoxime
BR9506663A (pt) Derivados do ácido hidroxâmico
BR9508824A (pt) Derivado de ácido imícido
FI965275A0 (fi) Aonglaoda i kartong- eller pappersmaskin
KR970048985U (ko) 도마
DE59703634D1 (de) Durchführung
FI2674U1 (fi) Långnyppress i en pappers- eller kartongmaskin
FI963104A0 (fi) Basskontroll i en hemteateranordning
FI964007A0 (fi) Styrsystem foer ventiler i en foerbraenningsmotor
FI965276A0 (fi) Aonglaoda i kartong- eller pappersmaskin